Literature DB >> 24338370

Early differences in dorsal hippocampal metabolite levels in males but not females in a transgenic rat model of Alzheimer's disease.

L H Nilsen1, T M Melø, M P Witter, U Sonnewald.   

Abstract

McGill-R-Thy1-APP rats express the human amyloid precursor protein carrying the Swedish and Indiana mutations. We examined the neurochemical content of the dorsal hippocampus in three-months-old male and female transgenic rats and healthy age- and gender-matched controls using in vivo (1)H MRS in order to assess early metabolite alterations and whether these were similar for both genders. Whereas male and female controls had similar levels of all metabolites, differences were evident between male and female McGill-R-Thy1-APP rats. Compared with McGill-R-Thy1-APP females, McGill-R-Thy1-APP males had lower levels of myo-inositol and N-acetylaspartate (NAA). No differences in metabolite levels were evident when female control and McGill-R-Thy1-APP rats were compared, whereas McGill-R-Thy1-APP males had lower levels of glutamate, NAA and total choline compared with male controls. In addition to metabolite concentrations, metabolite ratios are reported as these are widely used. The results from this preliminary study demonstrate early metabolite alterations in the dorsal hippocampus of males in this rat model of Alzheimer's disease, and imply that very early possible neurochemical markers of the disease are different for males and females.

Entities:  

Mesh:

Year:  2013        PMID: 24338370     DOI: 10.1007/s11064-013-1222-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

Authors:  S Narayanan; N De Stefano; G S Francis; R Arnaoutelis; Z Caramanos; D L Collins; D Pelletier; J P Antel; D L Arnold
Journal:  J Neurol       Date:  2001-11       Impact factor: 4.849

2.  Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging.

Authors:  Toshiyuki Watanabe; Akihiko Shiino; Ichiro Akiguchi
Journal:  Dement Geriatr Cogn Disord       Date:  2010-08-05       Impact factor: 2.959

3.  Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis.

Authors:  Kim A Celone; Vince D Calhoun; Bradford C Dickerson; Alireza Atri; Elizabeth F Chua; Saul L Miller; Kristina DePeau; Doreen M Rentz; Dennis J Selkoe; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  J Neurosci       Date:  2006-10-04       Impact factor: 6.167

4.  Impaired glutamatergic and GABAergic function at early age in AβPPswe-PS1dE9 mice: implications for Alzheimer's disease.

Authors:  Vivek Tiwari; Anant B Patel
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 5.  Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).

Authors:  L F Eng; R S Ghirnikar; Y L Lee
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

6.  Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease.

Authors:  Susanne G Mueller; Norbert Schuff; Kristine Yaffe; Catherine Madison; Bruce Miller; Michael W Weiner
Journal:  Hum Brain Mapp       Date:  2010-09       Impact factor: 5.038

7.  Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.

Authors:  Catherine M L Foy; Eileen M Daly; Amanda Glover; Ruth O'Gorman; Andrew Simmons; Declan G M Murphy; Simon Lovestone
Journal:  Brain Topogr       Date:  2011-02-05       Impact factor: 3.020

8.  Canadian study of health and aging: study methods and prevalence of dementia.

Authors: 
Journal:  CMAJ       Date:  1994-03-15       Impact factor: 8.262

9.  Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.

Authors:  Linn H Nilsen; Torun M Melø; Oddbjørn Saether; Menno P Witter; Ursula Sonnewald
Journal:  J Neurochem       Date:  2012-10-01       Impact factor: 5.372

10.  Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function.

Authors:  Jon Nilsen; Shuhua Chen; Ronald W Irwin; Sean Iwamoto; Roberta Diaz Brinton
Journal:  BMC Neurosci       Date:  2006-11-03       Impact factor: 3.288

View more
  7 in total

1.  Increased astroglial activity and reduced neuronal function across brain in AβPP-PS1 mouse model of Alzheimer's disease.

Authors:  Anant B Patel; Vivek Tiwari; Pandichelvam Veeraiah; Kamal Saba
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-06       Impact factor: 6.200

2.  Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice.

Authors:  Rachelle Crescenzi; Catherine DeBrosse; Ravi P R Nanga; Matthew D Byrne; Guruprasad Krishnamoorthy; Kevin D'Aquilla; Hari Nath; Knashawn H Morales; Michiyo Iba; Hari Hariharan; Virginia M Y Lee; John A Detre; Ravinder Reddy
Journal:  Hippocampus       Date:  2017-02-03       Impact factor: 3.899

3.  Age differences in brain structural and metabolic responses to binge ethanol exposure in fisher 344 rats.

Authors:  Natalie M Zahr; Edith V Sullivan; Kilian M Pohl; Adolf Pfefferbaum
Journal:  Neuropsychopharmacology       Date:  2020-06-24       Impact factor: 8.294

Review 4.  Sex Differences in Psychiatric Disease: A Focus on the Glutamate System.

Authors:  Megan M Wickens; Debra A Bangasser; Lisa A Briand
Journal:  Front Mol Neurosci       Date:  2018-06-05       Impact factor: 5.639

5.  Reproducibility of 2D GluCEST in healthy human volunteers at 7 T.

Authors:  Ravi Prakash Reddy Nanga; Catherine DeBrosse; Dushyant Kumar; David Roalf; Brendan McGeehan; Kevin D'Aquilla; Arijitt Borthakur; Hari Hariharan; Damodara Reddy; Mark Elliott; John A Detre; Cynthia Neill Epperson; Ravinder Reddy
Journal:  Magn Reson Med       Date:  2018-05-25       Impact factor: 4.668

6.  Electrophysiological Characterization of Networks and Single Cells in the Hippocampal Region of a Transgenic Rat Model of Alzheimer's Disease.

Authors:  Ingrid Heggland; Pål Kvello; Menno P Witter
Journal:  eNeuro       Date:  2019-02-22

7.  Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.

Authors:  Aisling M Chaney; Francisco R Lopez-Picon; Sophie Serrière; Rui Wang; Daniela Bochicchio; Samuel D Webb; Matthias Vandesquille; Michael K Harte; Christina Georgiadou; Catherine Lawrence; Julie Busson; Johnny Vercouillie; Clovis Tauber; Frédéric Buron; Sylvain Routier; Tristan Reekie; Anniina Snellman; Michael Kassiou; Johanna Rokka; Karen E Davies; Juha O Rinne; Dervis A Salih; Frances A Edwards; Llwyd D Orton; Stephen R Williams; Sylvie Chalon; Hervé Boutin
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.